ES8502865A1 - Procedimiento para producir una composicion farmaceutica nasal mejorada. - Google Patents

Procedimiento para producir una composicion farmaceutica nasal mejorada.

Info

Publication number
ES8502865A1
ES8502865A1 ES519450A ES519450A ES8502865A1 ES 8502865 A1 ES8502865 A1 ES 8502865A1 ES 519450 A ES519450 A ES 519450A ES 519450 A ES519450 A ES 519450A ES 8502865 A1 ES8502865 A1 ES 8502865A1
Authority
ES
Spain
Prior art keywords
medicinal composition
carbon dioxide
agent capable
ciliary function
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519450A
Other languages
English (en)
Other versions
ES519450A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8502865A1 publication Critical patent/ES8502865A1/es
Publication of ES519450A0 publication Critical patent/ES519450A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UNA COMPOSICION FARMACEUTICA NASAL MEJORADA.COMPRENDE LAS SIGUIENTES ETAPAS: PRIMERA, SE DISUELVE EN AGUA, PREFERIBLEMENTE SATURADA CON DIOXIDO DE CARBONO Y A UNA TEMPERATURA COMPRENDIDA ENTRE 5 Y 90 GRADOS, UN AGENTE CAPAZ DE AUMENTAR LA FUNCION CILIAR, TAL COMO CAFEINA; SEGUNDA, SE AN/ADE A DICHA SOLUCION UN AGENTE FARMACOLOGICAMENTE ACTIVO CAPAZ DE DISMINUIR LA FUNCION CILIAR, PREFERIBLEMENTE DIHIDROERGOTAMINA; Y POR ULTIMO, SE DILUYE LA SOLUCION FORMADA Y SE FILTRA A TRAVES DE UN FILTRO FINO, EN PRESENCIA DE DIOXIDO DE CARBONO.
ES519450A 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada. Granted ES519450A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
ES8502865A1 true ES8502865A1 (es) 1985-02-01
ES519450A0 ES519450A0 (es) 1985-02-01

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519450A Granted ES519450A0 (es) 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada.

Country Status (27)

Country Link
JP (1) JPS58134017A (es)
AT (1) AT385656B (es)
AU (1) AU565613B2 (es)
BE (1) BE895750A (es)
CA (1) CA1197783A (es)
CH (1) CH653555A5 (es)
DE (1) DE3302949A1 (es)
DK (1) DK164771C (es)
ES (1) ES519450A0 (es)
FI (1) FI81258C (es)
FR (1) FR2539994B1 (es)
GR (1) GR81320B (es)
HK (1) HK59989A (es)
HU (1) HU191512B (es)
IE (1) IE54532B1 (es)
IL (1) IL67822A (es)
IT (1) IT1197558B (es)
KE (1) KE3888A (es)
LU (1) LU84613A1 (es)
MY (1) MY8700766A (es)
NL (1) NL192325C (es)
NZ (1) NZ203117A (es)
PH (1) PH22198A (es)
PT (1) PT76166B (es)
SE (1) SE454402B (es)
SG (1) SG34389G (es)
ZA (1) ZA83673B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (ja) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IL67822A (en) 1988-02-29
AU1085083A (en) 1983-08-11
MY8700766A (en) 1987-12-31
IT8347646A0 (it) 1983-02-01
NL192325B (nl) 1997-02-03
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
IL67822A0 (en) 1983-06-15
IE830187L (en) 1983-08-01
ES519450A0 (es) 1985-02-01
PT76166A (en) 1983-02-01
IT8347646A1 (it) 1984-08-01
GR81320B (es) 1984-12-11
SE8300495L (sv) 1983-08-02
SE8300495D0 (sv) 1983-01-31
IE54532B1 (en) 1989-11-08
NZ203117A (en) 1986-12-05
BE895750A (fr) 1983-08-01
FI81258B (fi) 1990-06-29
SG34389G (en) 1989-09-22
ATA30383A (de) 1987-10-15
NL192325C (nl) 1997-06-04
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
FI81258C (fi) 1990-10-10
DK164771B (da) 1992-08-17
JPH0253406B2 (es) 1990-11-16
NL8300325A (nl) 1983-09-01
FR2539994A1 (fr) 1984-08-03
HK59989A (en) 1989-08-04
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
HU191512B (en) 1987-02-27
FI830245A0 (fi) 1983-01-25
DK38183A (da) 1983-08-02
CH653555A5 (de) 1986-01-15
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
AU565613B2 (en) 1987-09-24
AT385656B (de) 1988-05-10
PH22198A (en) 1988-06-28
JPS58134017A (ja) 1983-08-10
FI830245L (fi) 1983-08-02
DE3302949C2 (es) 1992-05-21
LU84613A1 (fr) 1983-09-08
DE3302949A1 (de) 1983-08-11
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
ATE80548T1 (de) Medizinischer fluessigkeitsbehaelter und dessen herstellung.
GB1525448A (en) Dialysis membrane for haemodialysis
CS193084B2 (en) Means with the insecticide and ovicide effect and method of making the active agents
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
AR224111A1 (es) Derivados de 1-oxido de acido penicilanico,desprovistos de actividad terapeutica,utiles como intermediarios en la preparacion de 1,1-dioxido de acido penicilanico farmaceuticamente activos,procedimiento para preparar dichos intermediarios y procedimiento para preparar los 1,1-dioxidos de acido penicilanico farmaceuticamente activos partiendo de dichos intermediarios
BR9809177A (pt) Comprimidos, e processo para fabricação de comprimidos
EA200200151A1 (ru) Сухая порошкообразная композиция
FR2347134A1 (fr) Procede de fabrication de corps en metaux frittes notamment d'electrodes de batteries
ZA80647B (en) Active electrode,electrochemical cell comprising the electrode and method of forming electrode
JPS6434909A (en) Cosmetic
IL97607A0 (en) Retinoids,their manufacture and pharmaceutical compositions containing them
JPS5359018A (en) Concentrated xiii-th blood coagulating factor derived from human placentaand its preparation
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
IE38028B1 (en) Improvements in and relating to ingestible topical and other compositions
ES509417A0 (es) Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
SE8101963L (sv) Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav
IE831551L (en) Eye ointment.
JPS57144214A (en) Pharmaceutical preparation for rectum medication
IT8026037A0 (it) Procedimento per comandare i movimenti dei blocchi forati nel laminatoio pellegrino al fine di ottimizzare il ritmo operativo, e dispositivo per realizzare il procedimento.
USD221365S (en) Medical diagnostic console
ES2017935B3 (es) Derivado del acido 4-metoxi-isoftalico que tiene una actividad farmacologica en las afecciones tromboembolicas, y un procedimiento para su preparacion.
GR77250B (es)
JPS5448711A (en) Racemization of optical active nnacyllamino acid in the atate of aqueous solution
IE46070L (en) Bronchial spasm and respiratory relief

Legal Events

Date Code Title Description
PC1A Transfer granted